Patent · US Active

Formulations of pyrrolopyridine-aniline compounds

US12310950B2 · kind B2 · utility

0Cited by
6References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 22, 2022
Grant dateMay 27, 2025
Priority date
Expiry dateMay 9, 2043

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB64U2101/60
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are topical formulations including a compound of formula (I) and methods of using these topical formulations for the treatment of skin diseases, wherein the topical formulations include non-aqueous gel, aqueous gel, and emulsion-based formulations; and the compound of formula (I) is represented by wherein R1, R2, R2a, R3, R3a, and R3b are as defined and described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.